🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.95
-0.55 (-3.79%)
At close: Nov 19, 2026

Daiken Biomedical Revenue

Daiken Biomedical had revenue of 603.20M TWD in the quarter ending September 30, 2026, with 34.24% growth. This brings the company's total for the last twelve months to 2.34B, up 31.22% year-over-year. In the year 2025, Daiken Biomedical had annual revenue of 1.90B with 39.10% growth. That makes Daiken Biomedical the 25,354th largest company in the world by revenue and 1,144th in Taiwan.

Revenue (ttm)
2.34B
Revenue Growth
+31.22%
P/S Ratio
4.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.24B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.90B532.70M39.10%
Dec 31, 20241.36B171.97M14.45%
Dec 31, 20231.19B305.45M34.52%
Dec 31, 2022884.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.